Buprenorphine Injection Among Rural Persons Who Inject Drugs.
作者信息
Zinsli Kaitlin A, Bhatraju Elenore P, Feinberg Judith, Stopka Thomas J, Friedmann Peter D, Zule William, Cooper Hannah L F, Young April M, Korthuis P Todd, Pho Mai T, Jenkins Wiley D, Miller William C, Go Vivian F, Seal David W, Westergaard Ryan P, Fredericksen Rob J, Delaney Joseph A, Tsui Judith I
机构信息
Department of Epidemiology, University of Washington, Seattle.
Department of Medicine, University of Washington School of Medicine, Seattle.
出版信息
JAMA Netw Open. 2024 Dec 2;7(12):e2450108. doi: 10.1001/jamanetworkopen.2024.50108.
Abstract
摘要
相似文献
1
Buprenorphine Injection Among Rural Persons Who Inject Drugs.
JAMA Netw Open. 2024 Dec 2;7(12):e2450108. doi: 10.1001/jamanetworkopen.2024.50108.
2
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities.
Int J Drug Policy. 2023 Oct 6:104222. doi: 10.1016/j.drugpo.2023.104222.
3
Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review.
Harm Reduct J. 2022 Oct 13;19(1):113. doi: 10.1186/s12954-022-00695-5.
4
Prevalence and correlates of receptive syringe-sharing among people who inject drugs in rural Appalachia.
Addiction. 2021 Feb;116(2):328-336. doi: 10.1111/add.15151. Epub 2020 Jul 14.
5
Intersecting Structural and Psychosocial Conditions: Investigating Injection Drug Use and HIV Among Transgender Women.
J Acquir Immune Defic Syndr. 2025 Feb 1;98(2):123-132. doi: 10.1097/QAI.0000000000003543.
6
Prevalence and correlates of multiple injections per injection episode among people who inject drugs in rural U.S. communities.
Int J Drug Policy. 2025 May 30;143:104837. doi: 10.1016/j.drugpo.2025.104837.
7
Risk factors for multiple skin abscesses among community-recruited people who inject drugs in Los Angeles, CA, and Denver, CO: a cross-sectional study.
Ther Adv Infect Dis. 2025 Jun 25;12:20499361251344765. doi: 10.1177/20499361251344765. eCollection 2025 Jan-Dec.
8
Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations.
Addict Sci Clin Pract. 2023 Feb 14;18(1):11. doi: 10.1186/s13722-023-00364-3.
9
Comparative Effectiveness of Buprenorphine/Naloxone and Methadone on Methamphetamine/Amphetamine Use Among People with Opioid Use Disorder in Canada.
Subst Use Addctn J. 2025 Jul;46(3):518-530. doi: 10.1177/29767342241298044. Epub 2024 Nov 29.
10
Patterns of drug use among people who inject drugs: A global systematic review and meta-analysis.
Int J Drug Policy. 2024 Jun;128:104455. doi: 10.1016/j.drugpo.2024.104455. Epub 2024 May 25.
本文引用的文献
1
Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review.
Harm Reduct J. 2022 Oct 13;19(1):113. doi: 10.1186/s12954-022-00695-5.
2
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis.
Addict Sci Clin Pract. 2022 Jul 26;17(1):38. doi: 10.1186/s13722-022-00322-5.
3
Beyond harm-producing versus harm-reducing: A qualitative meta-synthesis of people who use drugs' perspectives of and experiences with the extramedical use and diversion of buprenorphine.
J Subst Abuse Treat. 2022 Apr;135:108651. doi: 10.1016/j.jsat.2021.108651. Epub 2021 Oct 28.
4
Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States.
Drug Alcohol Depend. 2021 Nov 1;228:109081. doi: 10.1016/j.drugalcdep.2021.109081. Epub 2021 Sep 24.
5
"They're making it so hard for people to get help:" Motivations for non-prescribed buprenorphine use in a time of treatment expansion.
Int J Drug Policy. 2019 Sep;71:118-124. doi: 10.1016/j.drugpo.2019.06.019. Epub 2019 Jul 20.
6
Understanding the use of diverted buprenorphine.
Drug Alcohol Depend. 2018 Dec 1;193:117-123. doi: 10.1016/j.drugalcdep.2018.09.007. Epub 2018 Oct 12.
Zotero 插件